| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/29/1999 | CA2307114A1 Arylpiperazines as serotonin reuptake inhibitors and 5-ht1d.alpha. antagonists |
| 04/29/1999 | CA2307047A1 Pharmaceutical grade ginseng |
| 04/29/1999 | CA2306985A1 Novel use of compounds for anti-pruritic activity |
| 04/29/1999 | CA2306982A1 Use of moxonidine for the treatment of depression |
| 04/29/1999 | CA2306980A1 Novel polymorphic forms of cipamfylline |
| 04/29/1999 | CA2306965A1 Antibacterial carbapenems, compositions and methods of treatment |
| 04/29/1999 | CA2306960A1 Novel benzodiazepine derivatives as antiarrhythmic agents |
| 04/29/1999 | CA2306870A1 Bicyclic kinase inhibitors |
| 04/29/1999 | CA2306825A1 Therapeutic uses of quinoline derivatives |
| 04/29/1999 | CA2306808A1 Method for increasing the concentration of conjugated linoleic acid in milk and/or tissue fat of a ruminant |
| 04/29/1999 | CA2306731A1 Using polyamide nucleic acid oligomers to engender a biological response |
| 04/29/1999 | CA2306698A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 04/29/1999 | CA2306646A1 Combination therapy for reducing the risks associated with cardio- and cerebrovascular disease |
| 04/29/1999 | CA2306632A1 Carbapenem antibacterial compounds, compositions and methods of treatment |
| 04/29/1999 | CA2306565A1 Carbapenem antibacterial compounds, compositions and methods of treatment |
| 04/29/1999 | CA2306414A1 Compositions based on plant extracts |
| 04/29/1999 | CA2306233A1 Potentiation of pharmaceuticals |
| 04/29/1999 | CA2306204A1 J-chain and analogues as epithelial cell targeting conjugates |
| 04/29/1999 | CA2306110A1 Therapeutic agent of uterine leiomyoma, containing dienogest as effective ingredient |
| 04/29/1999 | CA2306085A1 Intra-cancer-cell nuclease activator |
| 04/29/1999 | CA2306080A1 Novel methylenebisphosphonic acid derivatives |
| 04/29/1999 | CA2305891A1 New species of lactic acid bacterium |
| 04/29/1999 | CA2305798A1 .alpha.-aryl-n-alkylnitrones and pharmaceutical compositions containing the same |
| 04/29/1999 | CA2275773A1 Oral cyclosporin formulations |
| 04/28/1999 | EP0911634A1 Pharmaceutical uses of CDK-2 regulators |
| 04/28/1999 | EP0911633A1 A method of identifying agonists and antagonists for tumor necrosis related receptors TR1, TR3 and TR5 |
| 04/28/1999 | EP0911413A2 Minimal adenovirus-based gene therapy vector |
| 04/28/1999 | EP0911410A2 Era polynucleotides and polypeptides from Streptococcus pneumoniae belonging to the GTPase family |
| 04/28/1999 | EP0911409A2 Deformylase |
| 04/28/1999 | EP0911407A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 04/28/1999 | EP0911405A2 Gapdh |
| 04/28/1999 | EP0911403A2 MurB gene from Streptococcus pneumoniae |
| 04/28/1999 | EP0911402A2 PyrR homolog from Staphylococcus aureus |
| 04/28/1999 | EP0911399A2 A kringle-related clone, HTHBZ47 |
| 04/28/1999 | EP0911397A1 Tumor antigen proteins, genes thereof, and tumor antigen peptides |
| 04/28/1999 | EP0911388A2 Method for stimulation of T-cells with desired antigenspecificity |
| 04/28/1999 | EP0911340A2 Substituted Isoquinolin-3-Carboxyamides, their preparation and medical use |
| 04/28/1999 | EP0911334A1 Quinolinomorphinane derivatives and medicinal use thereof |
| 04/28/1999 | EP0911333A1 Pyrazolo[4,3-d]pyrimidine derivatives and pharmaceutical compositions containing them |
| 04/28/1999 | EP0911331A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 04/28/1999 | EP0911327A1 Novel pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredient |
| 04/28/1999 | EP0911321A2 Compounds for the treatment of osteoporosis |
| 04/28/1999 | EP0911319A1 Malonic acid based matrix metalloproteinase inhibitors |
| 04/28/1999 | EP0911038A1 Anhydrous composition comprising lactulose |
| 04/28/1999 | EP0911031A2 Use of arsenic for preparing a medicament for the treatment of premenstrual syndrome |
| 04/28/1999 | EP0911030A2 Antimicrobial composition comprising a vinyyl pyrrolidinon derivative and a carbapenem antibiotic or a beta-lactamase inhibitor |
| 04/28/1999 | EP0911029A2 Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
| 04/28/1999 | EP0911028A2 Method for treating sexual dysfunction |
| 04/28/1999 | EP0911027A1 Peripheral circulation improvers for ophthalmic tissues containing dihydropyridines |
| 04/28/1999 | EP0911026A1 Creatine derivatives for asthma |
| 04/28/1999 | EP0911020A1 Methylstyrene derivatives as UV-filters and cosmetic and pharmaceutical preparations containing them |
| 04/28/1999 | EP0911019A1 Deodorizing compositions based on flavone derivatives and/or flavanone derivatives, especially flavonoids |
| 04/28/1999 | EP0911016A1 Use of ascorbyl-2-phosphoric acid esters for stabilising vitamin a and/or vitamin a-derivatives in cosmetic and pharmaceutic compositions |
| 04/28/1999 | EP0910659A2 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 04/28/1999 | EP0910657A1 Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus |
| 04/28/1999 | EP0910656A1 Virus-like particles useful as a vector for delivering nucleic acid |
| 04/28/1999 | EP0910654A1 Enzyme combinations for destroying proliferative cells |
| 04/28/1999 | EP0910653A2 A cytoplasmic gene expression system which utilizes a prokaryotic rna polymerase autogene |
| 04/28/1999 | EP0910645A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/1999 | EP0910641A1 Neural cell adhesion molecule splicing variants |
| 04/28/1999 | EP0910639A1 HUMAN cAMP-DEPENDENT PROTEIN KINASE INHIBITOR HOMOLOG |
| 04/28/1999 | EP0910634A2 ANTISENSE INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEgF/VPF) EXPRESSION |
| 04/28/1999 | EP0910633A2 Polyketides and their synthesis |
| 04/28/1999 | EP0910628A1 Inactivation resistant factor viii |
| 04/28/1999 | EP0910579A1 Compounds with growth hormone releasing properties |
| 04/28/1999 | EP0910572A1 Inhibitors of picornavirus 3c proteases and methods for their use and preparation |
| 04/28/1999 | EP0910567A1 Tricyclic ibogaine analogs, their preparation and their use in treating substance abuse |
| 04/28/1999 | EP0910566A1 Heterocyclic compounds and their preparation and use |
| 04/28/1999 | EP0910565A1 Amide derivatives as selective neuropeptide y receptor antagonists |
| 04/28/1999 | EP0910564A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 04/28/1999 | EP0910563A1 Integrin receptor antagonists |
| 04/28/1999 | EP0910561A1 Inhibitors of oleamide hydrolase |
| 04/28/1999 | EP0910428A1 Photopheresis treatment of chronic hcv infections |
| 04/28/1999 | EP0910415A1 Fluoro labelled anthracyclinone and anthracycline derivatives |
| 04/28/1999 | EP0910413A2 TREATMENT OF ASTHMA WITH TNFR-Ig |
| 04/28/1999 | EP0910410A1 Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds |
| 04/28/1999 | EP0910409A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| 04/28/1999 | EP0910406A1 Recombinant canine herpesviruses |
| 04/28/1999 | EP0910403A1 Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof |
| 04/28/1999 | EP0910401A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same |
| 04/28/1999 | EP0910400A1 Therapies for chronic renal failure |
| 04/28/1999 | EP0910398A1 Method of stimulating cilia |
| 04/28/1999 | EP0910397A1 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 04/28/1999 | EP0910390A1 Pharmaceutical compositions containing alkylaryl polyether alcohol polymer |
| 04/28/1999 | EP0910389A1 Method of promoting bone growth with hyaluronic acid and growth factors |
| 04/28/1999 | EP0910388A1 Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and ulcer disease |
| 04/28/1999 | EP0910387A1 Apoptosis associated protein bbk |
| 04/28/1999 | EP0910386A1 Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv |
| 04/28/1999 | EP0910385A1 Sensitization of cells to radiation and chemotherapy |
| 04/28/1999 | EP0910384A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols |
| 04/28/1999 | EP0910383A1 The use of growth factor modulating compounds |
| 04/28/1999 | EP0910382A1 Treatment of carcinomas using squalamine in combination with other anti-cancer agents |
| 04/28/1999 | EP0910381A1 Method for treating pain |
| 04/28/1999 | EP0910380A1 Substituted benzylidene indenyl formamides, acetamides and propionamides |
| 04/28/1999 | EP0910379A1 Plaster for the transdermal application of pergolide |
| 04/28/1999 | EP0910378A1 Methods of increasing sphincter competence |
| 04/28/1999 | EP0910377A1 Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics |
| 04/28/1999 | EP0910376A2 Use of clotrimazole and related compounds in the treatment of diarrhea |
| 04/28/1999 | EP0910374A1 Pharmaceutical formulations for topical application containing as an active ingredient a carbazolyl-(4)-oxy-propanol amine derivate |
| 04/28/1999 | EP0910373A1 Use of substituted azaspirane in the treatment of asthma |